Igor Hall

Bachelor of Medicine and Bachelor of Science,  Massachusetts General Hospital 

Location: Germany

Consulting Services

Biostatistics IT-Web-Mobile Technology Hospital-Pharmacy-Insurance Admin and Customer Support Research Consulting

Areas Of Interest

Estrogen Receptors Clamoxyl Parenteral Collagen Type IV, alpha2 Chain Encephalomyelitis, Eastern Equine Infections, Staphylococcal Skin Epidermolysis Bullosa Dystrophica, Dominant Phosphorescent Measurements Sizes, Mitochondrial Splicing, Alternate Tremors, Nerve Ocular Administrations Unloadings, Hindlimb Artificially Sweetened Beverages Care Bundles G1 Phase Restriction Point Tetratricopeptide Repeat Mitogen Activated Protein Kinase 10 Clamps, Euglycaemic Low Molecular Weight Heparin Carbon Tetrachloride Human parainfluenza virus 4 Carbon Sulfur Lyases virology Hepatic Amebiasis Neoplasms, Thoracic Decarboxylases, Aromatic-L-Amino-Acid Out of Frame Deletion Cocultures Tree, Kamala Duodenoscopes Proxanol Fibrous Dysplasia, Craniomaxillofacial Cranial Nerve XI Injury

Professional Narrative

Dr. Igor Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Senior Director, Harvard Med 2013
Senior Director, Mayo Clinic 2004

Education

Doctor of osteopathic medicine, Weill Medical College 2007
Master of Science in physician assistant, Perelman School of Medicine 2014

Referees

Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02